Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:14 PM
Ignite Modification Date:
2025-12-24 @ 1:14 PM
NCT ID:
NCT00773695
Eligibility Criteria:
Inclusion Criteria:
* Histologically or cytologically confirmed, HER2-negative, men or pre- or post-menopausal women with primary operable adenocarcinoma of the breast, greater than or equal to (\>=) 2.5 centimeters (cm) in size
* Eastern Cooperative Oncology Group (ECOG)/world health organization (WHO) performance status less than or equal to (\</=) 2
* Normal baseline cardiac function (Left Ventricular Ejection Fraction \[LVEF\])
Exclusion Criteria:
* Stage IV (metastatic) disease
* Previous treatment for localized breast cancer less than (\<) 24 months from diagnosis of present breast cancer
* Other previous or current cancer except for basal cell cancer or in situ cervical cancer
* Current or recent use of aspirin (greater than \[\>\] 325 milligrams per day)
* Clinically significant cardiovascular disease
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00773695
Study Brief:
Protocol Section:
NCT00773695